- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Syntheia
CI Galaxy Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
A core group of shareholders that owns about three-quarters of Curaleaf’s issued and outstanding shares will extend a planned lockup agreement staggered on different dates.
Curaleaf Holdings (CSE:CURA,OTCQX:CURLF) shares dipped on Monday (October 21) after it confirmed an extension of a share lockup from insiders.
The Massachusetts-based cannabis firm told investors that a core group of shareholders that owns about three-quarters of Curaleaf’s issued and outstanding shares will extend a planned lockup agreement staggered on different dates.
The company’s share price had fallen 7.3 percent to C$7.65 by 11:15 a.m. EDT on Monday from an opening price of C$8.25. As of 12:51 p.m. EDT, Curaleaf sat at C$7.89.
The new agreement will limit the number of shares released in the lockup to 15 percent as of Monday. Moving forward, an additional 15 percent of the locked-up shares will be made available at the end of each subsequent calendar quarter. The final 10 percent of the shares will be released on March 31, 2021.
Since Curaleaf’s reverse takeover transaction in October 2018, all shareholders owning more than 1 percent of the company’s issued and outstanding shares have been under lockup agreements.
Curaleaf Executive Chairman Boris Jordan said in a statement that the lockup is a marker of continued support from shareholders.
“We expect the new lock-up release schedule to reduce uncertainty regarding the release of currently locked-up shares and provide for a more orderly increase in the available float in the Company’s shares.”
Cannabis companies look to improve market reputation
Curaleaf isn’t alone in trying to instill confidence in investors in an industry that’s seen a degree of volatility recently.
In July, Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF) CEO Kevin Murphy bought 154,000 shares of the company on the open market for more than US$2 million.
“With the downturn in industry stock prices recently, this was an opportunity to show investors that Acreage management is committed to creating long-term shareholder value,” Murphy said.
British Columbia-based Tilray (NASDAQ:TLRY) also locked up its shares with its investor Privateer Holdings, extending its existing lockup of 75 million shares.
As a part of a downstream merger, Tilray is to acquire Privateer and replace shareholders’ Privateer shares with Tilray shares. The new shares will be locked up for a two year period barring any special considerations.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Acreage Holdings is a client of the Investing News Network. This article is not paid-for content.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.